SC 13D Amendment No. 10

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 10)*

 

 

Acucela Inc.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

00510T 109

(CUSIP Number)

Masashi Okuyama

Legal & Compliance Dept. of SBI Holdings, Inc.

SBI Holdings, Inc.

Izumi Garden Tower 19F, 1-6-1 Roppongi, Minato-ku, Tokyo 106-6019, Japan

+81-3-6229-0122

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

June 15, 2016

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g) check the following box:   ¨

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13D

 

CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Holdings, Inc.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or place of organization

 

Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

-0-

     8   

Shared voting power

 

10,402,925

     9   

Sole dispositive power

 

-0-

   10   

Shared dispositive power

 

10,402,925

11  

Aggregate amount beneficially owned by each reporting person

 

10,402,925

12  

Check box if the aggregate amount in Row (11) excludes certain shares  ¨

 

13  

Percent of class represented by amount in Row (11)

 

27.8% (1)

14  

Type of reporting person

 

CO (Corporation organized in Japan)

 

(1) The calculations set forth in Row (13) for each Reporting Person is based on 37,445,276 shares of Common Stock, no par value, outstanding as of April 27, 2016, as reported on the Form 10-Q for the fiscal quarter ended March 31, 2016, filed by the Issuer with the Securities and Exchange Commission on May 10, 2016.


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Capital Management Co., Ltd.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or place of organization

 

Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

-0-

     8   

Shared voting power

 

6,196,869

     9   

Sole dispositive power

 

-0-

   10   

Shared dispositive power

 

6,196,869

11  

Aggregate amount beneficially owned by each reporting person

 

6,196,869

12  

Check box if the aggregate amount in Row (11) excludes certain shares  ¨

 

13  

Percent of class represented by amount in Row (11)

 

16.5%

14  

Type of reporting person

 

CO (Corporation organized in Japan)


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Investment Co., Ltd.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or place of organization

 

Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

-0-

     8   

Shared voting power

 

4,160,115

     9   

Sole dispositive power

 

-0-

   10   

Shared dispositive power

 

4,160,115

11  

Aggregate amount beneficially owned by each reporting person

 

4,160,115

12  

Check box if the aggregate amount in Row (11) excludes certain shares  ¨

 

13  

Percent of class represented by amount in Row (11)

 

11.1%

14  

Type of reporting person

 

CO (Corporation organized in Japan)


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Incubation Co., Ltd.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or place of organization

 

Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

-0-

     8   

Shared voting power

 

4,206,056

     9   

Sole dispositive power

 

-0-

   10   

Shared dispositive power

 

4,206,056

11  

Aggregate amount beneficially owned by each reporting person

 

4,206,056

12  

Check box if the aggregate amount in Row (11) excludes certain shares  ¨

 

13  

Percent of class represented by amount in Row (11)

 

11.2%

14  

Type of reporting person

 

CO (Corporation organized in Japan)


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

BIOVISION Life Science Fund No.1

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or place of organization

 

Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

-0-

     8   

Shared voting power

 

1,777,778

     9   

Sole dispositive power

 

-0-

   10   

Shared dispositive power

 

1,777,778

11  

Aggregate amount beneficially owned by each reporting person

 

1,777,778

12  

Check box if the aggregate amount in Row (11) excludes certain shares  ¨

 

13  

Percent of class represented by amount in Row (11)

 

4.7%

14  

Type of reporting person

 

PN (Limited partnership organized in Japan)


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Bio Life Science Investment LPS

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or place of organization

 

Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

-0-

     8   

Shared voting power

 

1,871,250

     9   

Sole dispositive power

 

-0-

   10   

Shared dispositive power

 

1,871,250

11  

Aggregate amount beneficially owned by each reporting person

 

1,871,250

12  

Check box if the aggregate amount in Row (11) excludes certain shares  ¨

 

13  

Percent of class represented by amount in Row (11)

 

5.0%

14  

Type of reporting person

 

PN (Limited partnership organized in Japan)


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI BB Mobile Investment LPS

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or place of organization

 

Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

-0-

     8   

Shared voting power

 

258,582

     9   

Sole dispositive power

 

-0-

   10   

Shared dispositive power

 

258,582

11  

Aggregate amount beneficially owned by each reporting person

 

258,582

12  

Check box if the aggregate amount in Row (11) excludes certain shares  ¨

 

13  

Percent of class represented by amount in Row (11)

 

0.7%

14  

Type of reporting person

 

PN (Limited partnership organized in Japan)


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Phoenix No. 1 Investment LPS

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)  ¨

 

  6  

Citizenship or place of organization

 

Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

-0-

     8   

Shared voting power

 

252,505

     9   

Sole dispositive power

 

-0-

   10   

Shared dispositive power

 

252,505

11  

Aggregate amount beneficially owned by each reporting person

 

252,505

12  

Check box if the aggregate amount in Row (11) excludes certain shares  ¨

 

13  

Percent of class represented by amount in Row (11)

 

0.7%

14  

Type of reporting person

 

PN (Limited partnership organized in Japan)


SCHEDULE 13D

Acucela Inc.

EXPLANATORY NOTE

The Statement on Schedule 13D originally filed by the persons named therein with the Securities and Exchange Commission on February 20, 2014, as amended by Amendment No. 1 dated September 30, 2014 and filed October 10, 2014; Amendment No. 2 dated January 28, 2015 and filed January 30, 2015; Amendment No. 3 dated March 2, 2015 and filed March 3, 2015; Amendment No. 4 dated March 13, 2015 and filed March 17, 2015; Amendment No. 5 dated March 31, 2015 and filed April 3, 2015; Amendment No. 6 dated and filed April 8, 2015; Amendment No. 7 dated May 1, 2015 and filed May 14, 2015; Amendment No. 8 dated November 26, 2015 and filed December 1, 2015; and Amendment No. 9 dated June 3, 2016 and filed June 7, 2016 (as so amended, the “Statement”), is hereby amended with respect to the items set forth below by this Amendment No. 10 (this “Amendment”). Capitalized terms used herein and not otherwise defined have the meanings assigned to such terms in the Statement. Except as otherwise provided herein, each Item of the Statement remains unchanged.

 

Item 3. Source and Amount of Funds or Other Consideration.

Item 3 of the Statement is hereby amended by adding the following paragraph to the end thereof:

“Between June 15, 2016 and June 17, 2016 SBI Incubation Co., Ltd. purchased 2,051,700 shares of Common Stock for an aggregate purchase price of $22,057,261, exclusive of any fees, commissions or other expenses (the “Share Purchase”). The funds were provided from SBI Incubation Co., Ltd.’s available cash resources.”

 

Item 5. Interest in Securities of the Issuer.

Item 5(a), (b) and (c) of the Statement are hereby deleted and replaced with the following:

“(a), (b)

As of the date hereof, each of the Reporting Persons may be deemed to beneficially own the aggregate number of and percentage of Common Stock listed opposite its name:


Reporting Person    Amount
Beneficially
Owned1
     Percent of
Class2
    Sole power
to vote or
direct the
vote
     Shared
power to
vote or
direct the
vote
     Sole power
to dispose
or direct
the
disposition
of
     Shared
power to
dispose or
direct the
disposition
of
 

SBI Holdings, Inc.

     10,402,925         27.8 %     0         10,402,925         0         10,402,925   

SBI Capital Management Co., Ltd.

     6,196,869         16.5 %     0         6,196,869         0         6,196,869   

SBI Investment Co., Ltd.

     4,160,115         11.1 %     0         4,160,115         0         4,160,115   

SBI Incubation Co., Ltd.

     4,206,056         11.2 %     0         4,206,056         0         4,206,056   

BIOVISION Life Science Fund No.1

     1,777,778         4.7 %     0         1,777,778         0         1,777,778   

SBI Bio Life Science Investment LPS

     1,871,250         5.0 %     0         1,871,250         0         1,871,250   

SBI BB Mobile Investment LPS

     258,582         0.7 %     0         258,582         0         258,582   

SBI Phoenix No. 1 Investment LPS

     252,505         0.7 %     0         252,505         0         252,505   

 

1  Each of the Reporting Persons expressly disclaims beneficial ownership of the Common Stock, except to the extent of such Reporting Person’s pecuniary interest therein.
2  The percentage ownership is based upon 37,445,276 outstanding shares as reported by the Issuer in its Form 10-Q filed with the Securities and Exchange Commission on May 10, 2016.

(c) The information contained in Items 3 and 4 to this Statement is herein incorporated by reference.

The weighted average price per share, exclusive of any fees, commissions or other expenses for the Share Purchase made by SBI Incubation Co., Ltd. between June 15, 2016 and June 17, 2016 are as set forth in the following table:

 

Purchase Date    Shares Purchased   

Weighted Average

Price Per Share

  

Price Range for

Shares Purchased

June 15, 2016

   1,018,400    $9.30    $8.98 - $11.42

June 16, 2016

   257,000    $11.13    $10.46 - $12.30

June 17, 2016

   776,300    $12.53    $10.82 - $13.54

SBI Incubation Co., Ltd. hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.

Other than with respect to the Share Purchase, none of (i) the Reporting Persons and, (ii) to the Reporting Persons’ knowledge, the persons set forth on Schedule A hereto has effected any transaction in the Issuer’s Common Stock during the past 60 days.”


SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date: June 17, 2016

 

SBI HOLDINGS, INC.
By:  

/s/ Yoshitaka Kitao

Name:   Yoshitaka Kitao
Title:   Representative Director, President & CEO
SBI CAPITAL MANGEMENT CO., LTD.
SBI INVESTMENT CO., LTD.,
SBI INCUBATION CO., LTD.,
BIOVISION LIFE SCIENCE FUND NO.1,
SBI BIO LIFE SCIENCE INVESTMENT LPS,
SBI BB MOBILE INVESTMENT LPS,
AND
SBI PHOENIX NO. 1 INVESTMENT LPS,
By:  

/s/ Katsuya Kawashima

Name:   Katsuya Kawashima
Title:   Authorized Signatory